Pharmatek Launches New API Manufacturing Program

News
Article

Pharmatek develops two new cGMP manufacturing suites for API-in-capsule productions.

Pharmatek, a contract development and manufacturing organization, has launched a new API-in-capsule manufacturing program. The program is designed to address manufacturing strategies that will lower development cost, shorten timelines, and increase capsule throughput for API-in-capsule productions.

As part of the program, Pharmatek has developed two new cGMP manufacturing suites designed specifically for API-in-capsule productions. The suites include humidity control and inert gas systems, which contribute to a stronger manufacturing process for API-in-capsule productions. In addition, Pharmatek has implemented operational systems to further address efficiencies, including new project teams, updated batch records, extended shift operations, redundant equipment and change parts, and on-demand inventory management.

Source: Pharmatek

Recent Videos
Drug Digest: Strategic Partnerships
Michelle Bridenbaker from Unbiased Science discusses her thoughts on the key industry from 2024 and those she anticipates will impact the industry in 2025 and beyond.
Henny Zijlstra from Adragos Pharma chats about the trends affecting the outsourcing market, various strategies being employed by service providers, and the value of end-to-end services.
Related Content